- Home
- IMMX vs UPLD Comparison
IMMX vs UPLD Comparison
Compare IMMX & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- UPLD
- Stock Information
- Founded
- IMMX 2014
- UPLD 2010
- Country
- IMMX United States
- UPLD United States
- Employees
- IMMX N/A
- UPLD N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- UPLD Computer Software: Prepackaged Software
- Sector
- IMMX Health Care
- UPLD Technology
- Exchange
- IMMX Nasdaq
- UPLD Nasdaq
- Market Cap
- IMMX 61.1M
- UPLD 51.0M
- IPO Year
- IMMX 2021
- UPLD 2014
- Fundamental
- Price
- IMMX $2.21
- UPLD $1.89
- Analyst Decision
- IMMX Strong Buy
- UPLD Hold
- Analyst Count
- IMMX 1
- UPLD 1
- Target Price
- IMMX $7.00
- UPLD N/A
- AVG Volume (30 Days)
- IMMX 252.3K
- UPLD 132.5K
- Earning Date
- IMMX 08-11-2025
- UPLD 07-31-2025
- Dividend Yield
- IMMX N/A
- UPLD N/A
- EPS Growth
- IMMX N/A
- UPLD N/A
- EPS
- IMMX N/A
- UPLD N/A
- Revenue
- IMMX N/A
- UPLD $267,713,000.00
- Revenue This Year
- IMMX N/A
- UPLD N/A
- Revenue Next Year
- IMMX N/A
- UPLD N/A
- P/E Ratio
- IMMX N/A
- UPLD N/A
- Revenue Growth
- IMMX N/A
- UPLD N/A
- 52 Week Low
- IMMX $1.26
- UPLD $1.69
- 52 Week High
- IMMX $3.00
- UPLD $5.64
- Technical
- Relative Strength Index (RSI)
- IMMX 45.97
- UPLD 48.41
- Support Level
- IMMX $2.16
- UPLD $1.73
- Resistance Level
- IMMX $2.31
- UPLD $1.85
- Average True Range (ATR)
- IMMX 0.17
- UPLD 0.10
- MACD
- IMMX -0.04
- UPLD 0.04
- Stochastic Oscillator
- IMMX 11.14
- UPLD 87.04
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.